Sun, 28 January 2018
Sales forecasting is big business. If you can better predict how much of a certain product or service you will sell in a given day, you can better stock inventory, better staff your facilities, and ultimately keep more margin in your business's accounts.
This week on AI in Industry we interview Dr. John-Paul B Clarke, professor at Georgia Tech and co-founder / Chief Scientist at Pace (previously called "Prix"). Dr. Clarke shares details about how sales predictions are done today, and what AI advancements may allow for in helping businesses sell everything from groceries to hotel rooms.
Read the full interview article online at:
Tue, 23 January 2018
In this episode of AI in industry, Innoplexus CEO Gunjan Bhardwaj explores how pharma giants are working to overcome two critical challenges with AI: Data, and talent.
Pharmaceutical data is challenging because the same term (say "EGFR") might be referred to as a "protein", a "biomarker", or a "target". Gunjan explores how this kind of relevance and context for data - and how pharma companies may need to hire the talent issues involved with making life sciences and computer sciences teams work together productively.
See the full interview article online at:
Sun, 21 January 2018
This week, AI in Industry features Jeremy Barnes, Chief Architect at Element AI. Jeremy talks about the common mistakes some businesses might make while adopting AI to solve broad business problems. He also sheds light on the problem areas that could raise the market value of businesses through AI adoption, hiring the right talent with the right combination of subject matter expertise and business experience, and the business and technical aspects executives should consider before contemplating the adoption of AI.
For more insights on the B2B applications of AI, go to techemergence.com
Sat, 13 January 2018
This week, AI in Industry features Dr. David Franke, Chief Scientist at Vast. David talks about how AI can work with scarce transaction data to derive meaningful analytics for big purchases, such as cars and houses. He elaborates on how the AI can glean information from user interaction and marketplace data to provide customers with the relevant product fit, deals and recommendations on big purchases. He also discusses the future trends and business benefits for early adopters of AI for purchase recommendations of high-cost items.
For more insights on this topic, go to www.techemergence.com
Sat, 6 January 2018
This week’s episode covers the medical applications of machine vision for the diagnosis and treatment of cancer. Medical science has integrated AI since the late 90s, and it’s been useful in the fight against cancer. This week’s guest is Dr. Alexandre Le Bouthillier, founder of Imagia. Imagia is a medical imaging company which specializes in using AI and machine learning to detect cancer in its early stages so that oncologists can make quicker, more accurate diagnoses for patients.
AI is a useful tool in the detection of breast cancer, colon cancer, and lung cancer. It can even detect genetic mutations, something humans certainly cannot. Learn just how important AI has been over the last two decades in developing the medical infrastructure necessary for patients to have a chance at surviving and even curing their cancer.
See the full interview article - with images and audio included - on TechEmergence:
Direct download: AI_in_Industry-Alexandre_Le_Bouthillier-Mixdown.mp3
Category:Artificial Intelligence -- posted at: 5:13pm PDT